Package 0121-4727-10

{"route": ["ORAL"], "spl_id": "d56a22ea-5dab-e98a-e053-2a95a90a34c4", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["884KT10YB7"], "rxcui": ["705610"], "spl_set_id": ["d0da9dd6-c691-4614-99c7-531b0bf34837"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Pharmaceutical Associates, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 TRAY in 1 CASE (0121-4727-10)  / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE", "package_ndc": "0121-4727-10", "marketing_start_date": "20101101"}], "brand_name": "Ranitidine", "product_id": "0121-4727_d56a22ea-5dab-e98a-e053-2a95a90a34c4", "dosage_form": "SYRUP", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "0121-4727", "generic_name": "RANITIDINE", "labeler_name": "Pharmaceutical Associates, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranitidine", "active_ingredients": [{"name": "RANITIDINE", "strength": "15 mg/mL"}], "application_number": "ANDA077405", "marketing_category": "ANDA", "marketing_start_date": "20101101", "listing_expiration_date": "20261231"}